Alzheimer's Disease Trial, Not Yet Recruiting NCT07376135 Sponsor: Medical University of Vienna Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT07376135
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are between 55 and 75 years old at the time of screening.
  • People who are fluent in German.
  • People who are able and willing to sign a written consent form before any study activities begin.
  • People who own a compatible Android smartphone, or who are willing and able to use a smartphone provided by the study for the duration of the trial.
  • People who feel their memory or thinking has declined, and/or who have a parent or sibling diagnosed with dementia.
  • People who are willing to make meaningful changes in at least three of the following six areas: diet, physical activity, brain training, managing heart and blood vessel health, social interaction, and sleep and relaxation.
  • People whose thinking and memory abilities are at or just below what is typical for their age, based on two specific cognitive tests (the m-TICS and MoCA) (confirm with trial site for exact score requirements).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have been diagnosed with, or are suspected of having, dementia or significant cognitive impairment — including those whose cognitive test scores fall below certain thresholds — or who currently use or have previously used medication for Alzheimer's disease or other forms of dementia.
  • People who have a significant neurological condition, such as Parkinson's disease, Huntington's disease, brain tumours, multiple sclerosis, epilepsy, or a history of serious head injury with lasting neurological effects, among others.
  • People who lack the capacity to make decisions, cannot provide informed consent, are unable to complete study assessments, or have any condition that would prevent them from cooperating effectively with the study, as determined by a clinician.
  • People who have severe difficulties with vision, hearing, or communication that would prevent them from taking part in study procedures.
  • People who have a medical or psychiatric condition that could make participation unsafe, including active cancer, major depression, symptomatic heart or cardiovascular disease, or who have had a heart or blood vessel procedure within the past year.
  • People who are currently taking part in another interventional clinical trial, unless the study team determines that this would not interfere with participation in this trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4915154733860

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
8 January 2026
Est. completion
1 October 2027

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Operational feasibility: retention rate; Operational feasibility: adherence to the structured hybrid lifestyle intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov